Clozapine Nitroso Impurity 1 - Request Quote
Clozapine Nitroso Impurity 1
| SZ CAT No: | SZ-C008027 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clozapine Nitroso Impurity 1 is chemically 2-((2-Amino-4-chlorophenyl)(nitroso)amino)benzoic acid. Clozapine Nitroso Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Clozapine Nitroso Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clozapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Clozapine Nitroso Impurity 1
Purchase Clozapine Nitroso Impurity 1
Clozapine Nitroso Impurity 1 suppliers
Clozapine Nitroso Impurity 1 manufacturers
Clozapine Nitroso Impurity 1 price
Order Clozapine Nitroso Impurity 1
Enquire Clozapine Nitroso Impurity 1
Clozapine Nitroso Impurity 1 cost
Clozapine Nitroso Impurity 1 Supplier
Clozapine Nitroso Impurity 1 Distributor
Clozapine Nitroso Impurity 1 for Method Validation
Clozapine Reference Standard
Clozapine Nitroso Impurity 1 for ANDA Filing
Clozapine Nitroso Impurity 1 for Forced Degradation Studies
Clozapine Nitroso Impurity 1 Identification Standards
Clozapine Nitroso Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


